If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,244.00    9.00 (0.73%)
Bid:
1,236.00
Ask:
1,239.00
Spread: 3.00 (0.243%)
Market Cap: £860.84m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Long Term Incentive Plan Awards

16 Oct 2018 12:51

RNS Number : 2183E
CVS Group plc
16 October 2018
 

16 October 2018

CVS Group plc

("CVS" or the "Company")

Long Term Incentive Plan Awards

CVS, the UK's leading provider of integrated veterinary services, announces that on 12 October 2018 it made a grant of awards over the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") under the CVS Group Long Term Incentive Plan 2017 ("LTIP") to certain Directors and employees to subscribe for 187,114 Ordinary Shares (the "Options"). The awards to Directors are detailed in the table below:

Name

Role

Number of Ordinary

Shares subject to LTIP award

 

Simon Innes

Chief Executive

63,797

Richard Fairman

Finance Director

30,969

The awards will vest in three years' time subject to certain performance criteria related to earnings per share growth over a three-year performance period between 1 July 2018 and 30 June 2021 being satisfied.

Further details of the awards are set out below.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Simon Innes

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

 

Grant of Options under the LTIP

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Exercise price of 0.2p

63,797

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

 

e)

 

Date of the transaction

 

 

12 October 2018

f)

 

Place of the transaction

 

 

Off market

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Richard Fairman

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Finance Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

 

Grant of Options under the LTIP.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Exercise price of 0.2p

30,969

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

 

e)

 

Date of the transaction

 

 

12 October 2018

f)

 

Place of the transaction

 

 

Off market

 

 

 

Contacts:

CVS Group plc

Simon Innes, Chief Executive

Richard Fairman, Finance Director

 

 

Tel: 01379 644 288

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell

Jennifer Boorer

Tel: 020 7496 3000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFQLFFVBFZFBK
Date   Source Headline
24th Nov 20253:30 pmRNSStandard form for notification of major holdings
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20254:49 pmRNSStandard form for notification of major holdings
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20255:35 pmRNSStandard form for notification of major holdings
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20252:50 pmRNSResult of AGM
18th Nov 20257:00 amRNSAGM Statement and Trading Update
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20254:31 pmRNSPDMR Dealing
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTotal Voting Rights
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:06 amRNSCommencement of Share Buyback Programme
24th Oct 20257:00 amRNSIntention to move to Main Market & Buyback Scheme
17th Oct 20257:00 amRNSPosting of Annual Report & Notice of AGM
15th Oct 20257:35 amRNSResponse to CMA provisional decision announcement
7th Oct 20257:00 amRNSFinal results for the year ended 30 June 2025
30th Sep 20257:00 amRNSTotal Voting Rights
15th Sep 20254:50 pmRNSPDMR Shareholding Correction
11th Sep 20254:53 pmRNSHolding(s) in Company
9th Sep 20259:46 amRNSHolding(s) in Company
5th Sep 20259:30 amRNSNotification of major holdings
29th Aug 20254:42 pmRNSTotal Voting Rights
5th Aug 202511:19 amRNSStandard form for notification of major holdings
1st Aug 202510:31 amRNSLTIP Awards and PDMR Dealing
31st Jul 20257:00 amRNSTotal Voting Rights
24th Jul 20257:00 amRNSFull year trading update
15th Jul 20255:00 pmRNSStandard form for notification of major holdings
14th Jul 20257:00 amRNSBlock listing Interim Review
11th Jul 20253:48 pmRNSDirector/PDMR Shareholding
2nd Jul 202510:00 amRNSStandard form for notification of major holdings
30th Jun 202510:01 amRNSStandard form for notification of major holdings
30th Jun 20257:00 amRNSTotal Voting Rights
10th Jun 20258:54 amRNSResponse to CMA announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.